Low-dose doxapram for treatment of apnoea following early weaning in very low birthweight infants: A randomized, double-blind study

Acta Paediatrica, International Journal of Paediatrics

Volumn 87, Issue 11, 1998, Pages 1180-1184

  Huon, C ^a   Rey, E ^a   Mussat, P ^a   Parat, S ^a   Moriette, G ^a  

^a Université René Descartes ^*  (France)

Author keywords

Adverse effects; Apnoea; Blood pressure; Doxapram; Mechanical ventilation; Premature infant; Very low birthweight

Indexed keywords

CAFFEINE CITRATE; DOXAPRAM; PLACEBO; SODIUM CHLORIDE;

APNEA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; FEMALE; HUMAN; INTERMITTENT POSITIVE PRESSURE VENTILATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEWBORN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; VERY LOW BIRTH WEIGHT;

EID: 0031766388     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.1998.tb00927.x     Document Type: Article

References (23)

1. Alpan G, Eyal F, Sagi E, Springer C, Patz D, Goder K. Doxapram in the treatment of idiopathic apnea of prematurity unresponsive to aminophylline. i Pediatr 1984; 104: 634-7
2. Brion L, Vega-Rich C, Reinersman G, Roth P. Low dose doxapram for apnea unresponsive to aminophylline in very low birthweight infants. J Perinatol 1991; 11: 359-64
3. Bairam A, Boutroy M, Vert P. Un stimulant respiratoire, le doxapram, et ses applications en pédiatrie. Arch Fr Pédiatr 1992; 49: 469-74
4. Eyal F, Sagi E, Alpan G, Glick B, Arad I. Aminophylline versus doxapram in weaning premature infants from mechanical ventilation: preliminary report. Crit Care Med 1985; 13: 124-5
5. Pelioswki A, Finer N. A blinded, randomized, placebo-controlled trial to compare theophylline and doxapram for the treatment of apnea of prematurity. J Pediatr 1990; 116: 648-53
6. Bairam A, Vert P. Low-dose of Doxapram for apnea of prematurity. Lancet 1986; i: 793-4
7. Barrington K, Finer N, Peters K, Barton J. Physiologic effects of Doxapram in idiopathic apnea of prematurity. J Pediatr 1986; 108: 125-9
8. Kumita H, Mizuno S, Shinohara M, Ichikawa T, Yamazaki T. Lowdose doxapram therapy in premature infants and its CSF and serum concentrations. Acta Paediatr Scand 1991; 80: 786-91
9. Eyal F, Alpan G, Sagi E, Gkick B, Peleg O, Dgani Y, et al. Aminophylline versus Doxapram in idiopathic apnea of prematurity: a double-blind controlled study. Pediatrics 1985; 75: 709-13
10. Viscardi R, Faix R, Nicks J, Grasela T. Efficacy of theophylline for prevention of post-extubation respiratory failure in very low birthweight infants. J Pediatr 1985; 107: 469-72
11. Greenough A, Elias-Jones A, Pool J, Morley C, Davis J. The therapeutic actions of theophylline in preterm ventilated infants. Early Human Dev 1985; 12: 15-22
12. Durand D, Goodman A, Ray P, Ballard R, Clyman R. Theophylline treatment in the extubation of infants weighing less than 1250 g: a controlled trial. Pediatrics 1987; 80: 684-8
13. Pons G, Carrier O, Richard M-O, Rey E, d'Athis P, Moran C, et al. Developmental changes of caffeine elimination in infancy. Dev Pharmacol Ther 1988; 11: 258-64
14. Murat I, Moriette G, Blin M, Couchard M, Flouvat B, Gamarra E de, et al. The efficacy of caffeine in the treatment of recurrent idiopathic apnea in premature infants. J Pediatr 1981; 99: 984-9
15. Brouard C, Moriette G, Murat I, Flouvat B, Pajot N, Walti H, et al. Comparative efficacy of theophylline and caffeine in the treatment of idiopathic apnea in premature infants. Am J Dis Child 1985; 139: 698-700
16. Huon C, Moriette G, Mussat P, Parât S, Relier J-P. Use of preestablished criteria for deciding on extubation in the very low birthweight newborn: preliminary analysis of a randomized study. Biol Neonate 1993; 63: 75-9
17. Fanaroff A. In: Fanaroff A, Klaus M, editors. The year book of neonatal and perinatal medicine. St Louis: Mosby, 1995; 282-4
18. Bairam A, Blanchard P, Bureau M, Laudignon N, Cote A, Aranda J. Interactive ventilatory effects of two respiratory stimulants, caffeine and Doxapram, in newborn Iambs. Biol Neonate 1992; 61: 601-3
19. Barrington K, Finer N, Torok-Both G, Jamali F, Coutts R. Doseresponse relationship of doxapram in the therapy for refractory idiopathic apnea of prematurity. Pediatrics 1987; 80: 22-7
20. Bairam A, Blanchard P, Mullahoo K, Beharry K, Laudignon N, Aranda J. Pharmacodynamic effects and pharmacokinetic profiles of keto-doxapram and doxapram in newborn lambs. Pediatr Res 1990; 28: 142-6
21. Cote A, Blanchard P, Meehan B. Metabolic and cardiorespiratory effects of doxapram and theophylline in sleeping newborn piglets. J Appl Physiol 1992; 72: 410-5
22. Tay-Uyboco J, Kwiatkowski K, Gates D, Seifen B, Hasan S, Rigatto H. Clinical and physiological responses to prolonged nasogastric administration of Doxapram for apnea of prematurity. B iol Neonate 1991 ; 59: 190-200
23. Bumard ED, Moore RG, Nichol H. A trial of doxapram in the recurrent apnea of prematurity. In: Oh W, Friis-Hansen B, editors. Intensive care in the newborn. New York: Masson, 1978; 143-8